Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Retained Earnings: 2009-2024

Historic Retained Earnings for Gyre Therapeutics (GYRE) over the last 15 years, with Dec 2024 value amounting to -$73.5 million.

  • Gyre Therapeutics' Retained Earnings rose 9.12% to -$66.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.7 million, marking a year-over-year increase of 9.12%. This contributed to the annual value of -$73.5 million for FY2024, which is 14.13% up from last year.
  • Latest data reveals that Gyre Therapeutics reported Retained Earnings of -$73.5 million as of FY2024, which was up 14.13% from -$85.5 million recorded in FY2023.
  • Gyre Therapeutics' Retained Earnings' 5-year high stood at $7.4 million during FY2022, with a 5-year trough of -$402.7 million in FY2021.
  • In the last 3 years, Gyre Therapeutics' Retained Earnings had a median value of -$73.5 million in 2024 and averaged -$50.5 million.
  • Per our database at Business Quant, Gyre Therapeutics' Retained Earnings surged by 101.84% in 2022 and then plummeted by 1,256.70% in 2023.
  • Gyre Therapeutics' Retained Earnings (Yearly) stood at -$314.8 million in 2020, then dropped by 27.94% to -$402.7 million in 2021, then spiked by 101.84% to $7.4 million in 2022, then plummeted by 1,256.70% to -$85.5 million in 2023, then grew by 14.13% to -$73.5 million in 2024.